• White Facebook Icon
  • White LinkedIn Icon
  • White Twitter Icon

Artificial Intelligence for Drug Discovery Landscape Overview 2018 Industry Analysis

Q3/2018:

110 Page report

Untitled presentation (14).png

This 110-page report marks the fourth installment in a series of reports on the topic of the Artificial Intelligence in Drug Discovery Industry that Deep Knowledge Analytics have been producing for more than 1 year now. We released the first edition of these reports, entitled “AI for Drug Discovery Landscape Overview 2017”, in the end of 2017, followed by “AI for Drug Discovery & Advanced R&D Q1 2018” in the first quarter of 2018, and by “AI for Drug Discovery & Advanced R&D Q2 2018” in the second quarter of 2018.

The present edition consists of a shortened version of our previous 600-page report on the state of the industry in Q2 of 2018, updated with major developments having occurring in Q3 of 2018, and can be considered as a summary of the major insights, data analysis, conclusions and forecasts of our previous report.

Q2/2018:

Full 600 Page report

Untitled presentation (13).png

Section I: AI for Drug Discovery Landscape Overview (Industry Developments Q2 2018)

Section II: Novel Technologies & Trends (Industry Forecast 2019-2020), Appendices (which feature profiles of 100 Companies, 220 Investors, 15 Biopharma, 15 IT/Tech Corporations, and 20 leading R&D Centres active in the AI for Drug Discovery space) totalling 400 pages in length, has been made available free of charge.

Section III: Comparative Industry Analysis & Classification Framework

(Investor and M&A Guide), 70 pages in length,

specifically tuned to industry professionals such as investors, analysts, BioPharma/Tech executives and decision-makers, is available upon request.